

Other common side effects of NINLARO include low white blood cell counts and bronchitis.
Tell your healthcare provider if you get new or worsening signs or symptoms of the following during treatment with NINLARO:
These are not all the possible side effects of NINLARO. Talk to your healthcare provider for medical advice about side effects. You may report side effects to Takeda at 1-844-217-6468 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Females who are able to become pregnant:
Males with female partners who are able to become pregnant:
Taking too much NINLARO (overdose) can cause serious side effects, including death. If you take more NINLARO than instructed by your healthcare provider, call your healthcare provider right away or go to the nearest hospital emergency room right away. Take your medicine pack with you.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements or before starting any new medicines. Talk to your healthcare provider before starting any new medicines during treatment with NINLARO.
Please see Patient Information in the accompanying full Prescribing Information.
NINLARO is a prescription medicine used to treat multiple myeloma in combination with the medicines REVLIMID® (lenalidomide) and dexamethasone, in people who have received at least one prior treatment for their multiple myeloma.
NINLARO should not be used to treat the following people, unless they are participants in a controlled clinical trial:
It is not known if NINLARO is safe and effective in children.
Other common side effects of NINLARO include low white blood cell counts and bronchitis.
Tell your healthcare provider if you get new or worsening signs or symptoms of the following during treatment with NINLARO:
These are not all the possible side effects of NINLARO. Talk to your healthcare provider for medical advice about side effects. You may report side effects to Takeda at 1-844-217-6468 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Females who are able to become pregnant:
Males with female partners who are able to become pregnant:
Taking too much NINLARO (overdose) can cause serious side effects, including death. If you take more NINLARO than instructed by your healthcare provider, call your healthcare provider right away or go to the nearest hospital emergency room right away. Take your medicine pack with you.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements or before starting any new medicines. Talk to your healthcare provider before starting any new medicines during treatment with NINLARO.
Please see Patient Information in the accompanying full Prescribing Information.
NINLARO is a prescription medicine used to treat multiple myeloma in combination with the medicines REVLIMID® (lenalidomide) and dexamethasone, in people who have received at least one prior treatment for their multiple myeloma.
NINLARO should not be used to treat the following people, unless they are participants in a controlled clinical trial:
It is not known if NINLARO is safe and effective in children.